Back to Search
MATTHEW MEYERSON, M.D.
M.D.
Clinical Pathology/Laboratory Medicine Physician
NPI: 1205979697Individual
Specialties, Licenses & Credentials
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
152244(MA)
Research & Publications (20)
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
PMID 19040416·J Cell Mol Med·2009
8-other
Molecular classification and molecular genetics of human lung cancers.
PMID 14981576·Semin Oncol·2004
6-review
High-resolution mapping of copy-number alterations with massively parallel sequencing.
PMID 19043412·Nat Methods·2009
8-other
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
PMID 19470766·Cancer Res·2009
4-observational
Lin28 promotes transformation and is associated with advanced human malignancies.
PMID 19483683·Nat Genet·2009
7-preclinical
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
PMID 18932182·J Pathol·2009
8-other
The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors.
PMID 19136632·Proc Natl Acad Sci U S A·2009
8-other
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR.
PMID 19351834·Cancer Res·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- DANA-FARBER CANCER INSTI, M 430
BOSTON, MA 02115 - Phone
- (617) 632-4768
Quick Facts
- NPI
- 1205979697
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile